| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
821-50328103-801 18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:MRS 2279;(1R*,2S*)-4-[2-Chloro-6-(MethylaMino)-9H-purin-9-yl]-2-(phosphonooxy)bicyclo[3.1.0]hexane-1-MethanoldihydrogenphosphateesterdiaMMoniuMsalt
CAS:367909-40-8
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
| Company Name: |
EMMX Biotechnology LLC
|
| Tel: |
888-539-0666 |
| Email: |
info@emmx.com |
| Products Intro: |
Product Name:MRS 2279
CAS:367909-40-8
Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
| Company Name: |
Jinan Yaoyan Pharmaceutical Co., Ltd.
|
| Tel: |
|
| Email: |
jnyaoyan@163.com |
| Products Intro: |
Product Name:[(1S,2R,4R)-4-[(2-chloro-6-methylaminopurin-9-yl)methyl]-2-(phosphonooxymethyl)cyclopentyl] dihydrogen phosphate
CAS:367909-40-8
Purity:99% HPLC Package:1g,2g,5g;
|
|
| | MRS 2279 Basic information |
| Product Name: | MRS 2279 | | Synonyms: | MRS 2279;(1R*,2S*)-4-[2-Chloro-6-(methylamino)-9H-purin-9-yl]-2-(phosphonooxy)bicyclo[3.1.0]hexane-1-methanoldihydrogenphosphateesterdiammoniumsalt;[(1S,2R,4R)-4-[(2-chloro-6-methylaminopurin-9-yl)methyl]-2-(phosphonooxymethyl)cyclopentyl] dihydrogen phosphate;MRS 2279, CID: 5311301;Bicyclo[3.1.0]hexane-1-methanol, 4-[2-chloro-6-(methylamino)-9H-purin-9-yl]-2-(phosphonooxy)-, 1-(dihydrogen phosphate), (1R,2S,4S,5S)-;MRS2279,MRS-2279 | | CAS: | 367909-40-8 | | MF: | C13H18ClN5O8P2 | | MW: | 469.71 | | EINECS: | | | Product Categories: | | | Mol File: | 367909-40-8.mol |  |
| | MRS 2279 Chemical Properties |
| storage temp. | Desiccate at -20°C | | form | Powder | | Water Solubility | Soluble to 100 mM in water |
| | MRS 2279 Usage And Synthesis |
| Uses | MRS 2279 is a selective P2Y1 antagonist with high affinity and results in modulation of aggregation of blood platelets induced by ADP. | | Biological Activity | Selective, high affinity competitive antagonist of the P2Y 1 receptor (K i = 2.5 nM; IC 50 = 51.6 nM). Fails to block nucleotide signaling at most other P2Y receptors (P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 and P2Y 12 ) and potently inhibits ADP-induced aggregation of human blood platelets in vitro (pK B = 8.05). |
| | MRS 2279 Preparation Products And Raw materials |
|